Nima Nabavizadeh, M.D. (IMAGE)
Caption
Nima Nabavizadeh, M.D., a physician-scientist at OHSU Knight Cancer Institute, is principal investigator for the PATHFINDER 2 study. Results published in Nature Medicine show the GRAIL Galleri test the study is assessing dramatically improves multi-cancer early detection when used with routine screening. (OHSU/Christine Torres Hicks)
Credit
OHSU/Christine Torres Hicks
Usage Restrictions
For use with this study
License
Original content